HIGHLIGHTS
- who: Jie Chen and colleagues from the Department of Molecular Microbiology and Immunology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Biggy St, Los Angeles, CA, USA have published the Article: A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention, in the Journal: Cancers 2019, 11, 1909 of /2019/
- what: This study shows for the first time the principle and feasibility of DC vaccination (PDL1-Vax) to actively induce anti-PD-L1 antibody and T cell responses capable of inhibiting PD-L1+ tumor growth. The authors designed and tested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.